PLEKHB2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.294800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.751800E-01
Normal-vs-Stage2
7.961400E-01
Normal-vs-Stage3
4.727400E-01
Normal-vs-Stage4
2.890600E-01
Stage1-vs-Stage2
8.656000E-01
Stage1-vs-Stage3
3.242800E-01
Stage1-vs-Stage4
2.264400E-01
Stage2-vs-Stage3
1.929170E-01
Stage2-vs-Stage4
1.578190E-01
Stage3-vs-Stage4
1.278380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.504200E-01
Normal-vs-AfricanAmerican
4.933400E-01
Normal-vs-Asian
8.868200E-01
Caucasian-vs-AfricanAmerican
3.198600E-01
Caucasian-vs-Asian
4.789600E-01
AfricanAmerican-vs-Asian
3.380200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.762000E-01
Normal-vs-Female
9.009400E-01
Male-vs-Female
5.311600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.708000E-01
Normal-vs-Age(41-60Yrs)
4.520800E-01
Normal-vs-Age(61-80Yrs)
9.642000E-01
Normal-vs-Age(81-100Yrs)
9.450600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.825800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.525000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.041800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.878300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.236450E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.931200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.616400E-01
Normal-vs-Daily Drinker
7.684400E-01
Normal-vs-Weekly Drinker
9.131000E-01
Normal-vs-Occasional Drinker
4.683800E-01
Normal-vs-Social Drinker
9.029800E-01
Non Drinker-vs-Daily Drinker
9.270400E-01
Non Drinker-vs-Weekly Drinker
4.527600E-01
Non Drinker-vs-Occasional Drinker
4.323700E-02
Non Drinker-vs-Social Drinker
4.243600E-01
Daily Drinker-vs-Weekly Drinker
4.907600E-01
Daily Drinker-vs-Occasional Drinker
5.091700E-02
Daily Drinker-vs-Social Drinker
4.477400E-01
Weekly Drinker-vs-Occasional Drinker
3.162000E-01
Weekly Drinker-vs-Social Drinker
9.597800E-01
Occasional Drinker-vs-Social Drinker
2.159400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.410990E-01
Normal-vs-Grade 2
2.850000E-02
Normal-vs-Grade 3
1.174150E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.768100E-02
Grade 1-vs-Grade 3
2.618500E-02
Grade 1-vs-Grade 4
1.410990E-01
Grade 2-vs-Grade 3
6.614000E-01
Grade 2-vs-Grade 4
2.850000E-02
Grade 3-vs-Grade 4
1.174150E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.886400E-01
Normal-vs-NonDiabetic
9.173000E-01
Diabetic-vs-NonDiabetic
7.162400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.624400E-01
Normal-vs-NoPancreatitis
8.972400E-01
Pancreatitis-vs-NoPancreatitis
4.395400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.333000E-01
Normal-vs-N1
8.032800E-01
N0-vs-N1
7.832600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.794600E-01
Normal-vs-TP53-NonMutant
9.325800E-01
TP53-Mutant-vs-TP53-NonMutant
8.624200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
